A Clomiphene Citrate and Letrozol Varsus Tamoxifen and Letrozole as an Infertility Treatment in Women With Polycystic Ovary Syndrome

Pakistan Journal of Biological Sciences - Pakistan
doi 10.3923/pjbs.2015.300.303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Alert

Related search

Letrozole Versus Clomiphene for Infertility in the Polycystic Ovary Syndrome

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2014English

Combined Clomiphene Citrate-Metformin Versus Letrozole-Metformin in Achieving Pregnancy Among Women With Polycystic Ovary Syndrome

Gynecology & Reproductive Health
2019English

A Randomized Controlled Trial of Combination of Letrozole and Clomiphene Citrate Versus Letrozole Alone for Ovulation Induction in Women With Polycystic Ovary Syndrome

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Letrozole Versus Clomiphene Citrate in Patients With Anovulatory Infertility

Journal of SAFOG
GynecologyObstetrics
2009English

Usefulness of Intermittent Clomiphene Citrate Treatment for Women With Polycystic Ovarian Syndrome That Is Resistant to Standard Clomiphene Citrate Treatment

Reproductive Medicine and Biology
Reproductive MedicineCell Biology
2018English

L-Carnitine and Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome : Randomized Controlled Trial

Evidence Based Women's Health Journal
2020English

Infertility Treatment in Patients With Polycystic Ovary Syndrome (PCOS)

Journal of Fertilization: In vitro
2012English

Metformin Therapy for the Management of Infertility in Women With Polycystic Ovary Syndrome

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

A Review of Second- And Third-Line Infertility Treatments and Supporting Evidence in Women With Polycystic Ovary Syndrome

Medical Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy